ArticleBioImpacts : BI2025

Effectiveness of dolutegravir in moderate severity COVID-19 patients: A single-center, randomized, double-blind, placebo-controlled trial.

Hamideh Abbaspour Kasgari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.